Allergy Therapeutics plc (AGYTF)
OTCMKTS
· Delayed Price · Currency is USD
0.0820
-0.0180 (-18.00%)
At close: Apr 7, 2025
Allergy Therapeutics Employees
Allergy Therapeutics had 612 employees as of June 30, 2023. The number of employees decreased by 10 or -1.61% compared to the previous year.
Employees
612
Change (1Y)
-10
Growth (1Y)
-1.61%
Revenue / Employee
$113,854
Profits / Employee
-$72,927
Market Cap
408.35M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
SS Innovations International | 378 |
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
Glass House Brands | 374 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Allergy Therapeutics News
- 4 months ago - SMALL CAP IDEA: Allergy Therapeutics transformation has redefined its trajectory - This is Money
- 10 months ago - Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29% - GlobeNewsWire
- 3 years ago - Allergy Therapeutics announces FDA clearance of IND application for novel peanut allergy vaccine candidate VLP Peanut - GlobeNewsWire
- 4 years ago - Allergy Therapeutics reports a 6% annualised growth in revenue in fiscal 2020 - Invezz